InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Shabahang Shahrokh, Directeur de l'Innovation. Director active across 1 companies, notably Aditx Therapeutics, Inc.. In total, 4 filings have been recorded. Total volume traded: €3k. The latest transaction was filed on 1 June 2021 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations4 total
€1,175490 shares@ €2.398168.3% of flow
Common Stock
SEC:0001213900-21-030557·
Ideal exit: 26 Feb 2022 (T+270)
€1,175490 shares@ €2.398155.51% mcap34.1% of flow
Common Stock
SEC:0001213900-21-030557:0·
Ideal exit: 26 Feb 2022 (T+270)
€547279 shares@ €1.959331.7% of flow
Common Stock
SEC:0001213900-21-030054·
Ideal exit: 19 Feb 2022 (T+270)
€547279 shares@ €1.959325.82% mcap15.9% of flow
Common Stock
SEC:0001213900-21-030054:0·
Ideal exit: 19 Feb 2022 (T+270)
4 of 4 declarations
About Shabahang Shahrokh
Shabahang Shahrokh is the Chief Innovation Officer at Aditx Therapeutics, Inc. In this role, he is responsible for leading innovation initiatives and developing new products. His expertise is crucial for the organization's growth.
